---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-017571"
form_type: "8-K"
ticker: "BNBX"
cik: "0000744452"
company_name: "BNB PLUS CORP."
filed_at: "2023-02-09T23:59:59+00:00"
generated_at: "2026-06-19T21:09:07.707749+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Applied DNA Q1 revenues $5.3M (+26% YoY); operating loss narrows to $1.2M

## Summary
- Total revenues $5.3M vs $4.2M in prior-year period; clinical lab service rev $4.5M (+41% YoY).
- Gross profit $2.4M (45% margin) vs $1.1M (27%), driven by higher testing volumes and cost management.
- Operating loss $1.2M vs $4.7M loss a year ago; Adjusted EBITDA -$1.1M vs -$2.7M.
- Cash $12.9M at Dec 31, 2022; 7.3M warrants outstanding with potential proceeds of ~$26.6M.
- cGMP facility build-out initiated within HQ; PGx validation package to be filed with NYSDOH.

## SEC filing metadata
- accession: 0001104659-23-017571
- form_type: 8-K
- ticker: BNBX
- cik: 0000744452
- company_name: BNB PLUS CORP.
- filed_at: 2023-02-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/744452/000110465923017571/0001104659-23-017571-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/744452/000110465923017571/tm236000d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-017571
- JSON: https://secwatch.observer/filing/0001104659-23-017571.json
- Plain text: https://secwatch.observer/filing/0001104659-23-017571.txt

## Key facts
- Earnings Releases
  BNB PLUS CORP. reported first quarter of fiscal 2023, ended December 31, 2022 results: revenue $5.3 million.
  - Period: first quarter of fiscal 2023, ended December 31, 2022
  - Revenue: $5.3 million
  - Result: reported results
  source text: Applied DNA Reports First Quarter Fiscal 2023 Financial Results - Total Revenues of $5.3 Million
  evidence_url: https://www.sec.gov/Archives/edgar/data/744452/000110465923017571/0001104659-23-017571-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.